Madrona leads $60M funding into AI-powered drug discovery firm Terray Therapeutics

Pasadena, Calif.-based Terray Therapeutics, which mixes nanotechnology with synthetic intelligence, has raised $60 million in a Collection A funding spherical led by Seattle’s Madrona Enterprise Group. Terray’s chips are match with thousands and thousands of molecules that can be utilized for drug-target screening, with the ensuing information fed into machine studying fashions. Madrona has traditionally backed tech firms however is more and more investing in firms on the convergence of life and laptop sciences, akin to A-Alpha Bio, Ozette and Nautilus Biotechnology.